Agreement grants Stemline the global rights to develop and commercialize a preclinical small molecule targeting high unmet ...

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and ...

Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company"), a clinical-stage biotechnology company pioneering innovative cancer and viral infection ...

Insilico Medicine ('Insilico'), a clinical-stage generative artificial intelligence (AI)-driven drug discovery and development company, today announced the nomination of ISM1745, a potentially best-in ...

Invenra has launched its Rapid Antibody Discovery Service, designed to simplify and de-risk the preclinical development of ...

The blood-brain barrier (BBB) is a major hurdle for the development of systemically delivered drugs targeting diseases of the central nervous system (CNS). Because of this barrier there is a huge ...

Insilico Medicine (‘Insilico’), a clinical-stage generative artificial intelligence (AI)-driven drug discovery and ...

Adults working with pre-school children need to have a knowledge of child development and what is expected at each level of development, for example approximately what age babies start to walk, talk ...

Aadi Bioscience has rebooted its operations, transforming from a commercial business into a preclinical biotech ... and committing up to $265 million in development milestones and $540 million ...

to advance pre-clinical development of Shuttle Diagnostics, Inc.’s (a wholly-owned subsidiary of Shuttle Pharma) ligand to the prostate-specific membrane antigen (PSMA) as a potential diagnostic and ...